Live Breaking News & Updates on Zhou yi

Stay informed with the latest breaking news from Zhou yi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Zhou yi and stay connected to the pulse of your community

HUTCHMED Highlights Data to be Presented at AACR Congress 2024

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 05, 2024 -- HUTCHMED Limited today announces that new and updated data from several studies of compounds discovered by HUTCHMED will...

Veneto , Italy , Hong-kong , Texas , United-states , Beijing , China , Chongqing , National-taiwan-university-hospital , T-ai-pei , Taiwan , Huazhong

HUTCHMED Highlights Data to be Presented at AACR Congress 2024

HUTCHMED Highlights Data to be Presented at AACR Congress 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

National-taiwan-university-hospital , T-ai-pei , Taiwan , Chongqing , China , Veneto , Italy , Texas , United-states , Tongji , Sichuan , Ming-lu

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status

— NDA accepted and both fruquintinib and sintilimab granted Priority Review, following Breakthrough Therapy designation in July 2023 — — First regulatory filing for fruquintinib for use in...

Hong-kong , Shanghai , China , Hui-zhou , Guangdong , Macau , United-states , American , Daphne-zhang , Eli-lilly , Ben-atwell-alex-shaw , Adimab-incyte

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

China , Hong-kong , Shanghai , Hui-zhou , Guangdong , United-states , Macau , American , Adimab-incyte , Michael-shi , Daphne-zhang , Atholl-tweedie

HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC

— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients — — If...

Hong-kong , China , Poland , United-states , Shanghai , Polish , American , Ben-atwell , Zhou-yi , Atholl-tweedie , Astrazeneca , China-limited

HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated ...

— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and median OS not reached in treatment-naïve patients —

Hong-kong , China , United-states , Poland , Shanghai , Polish , American , Atholl-tweedie , Zhou-yi , Ben-atwell , Linkedin , Single-institution-study

HUTCHMED Reports 2023 Full Year Results and Provides Business Updates

HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , Macau-special-administrative-region , Macau-general- , Macau , Shanghai , Hong-kong , Hainan , United-states , Japan , Japanese , American , Eli-lilly

HUTCHMED Highlights Presentation of Phase III Data on

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...

Japan , Shanghai , China , Australia , United-states , Panmure , Victoria , Hong-kong , American , Atholl-tweedie , Ben-atwell-alex-shaw , Daphne-zhang

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shanghai , China , Japan , Hong-kong , Panmure , Victoria , Australia , United-states , American , Zhou-yi , Rui-hua-xu , Atholl-tweedie

HUTCHMED Highlights Presentation Of Phase III Data On Fruquintinib In Second-Line Gastric Cancer At ASCO Plenary Series Session

HUTCHMED Highlights Presentation Of Phase III Data On Fruquintinib In Second-Line Gastric Cancer At ASCO Plenary Series Session
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

China , Australia , Hong-kong , Japan , United-states , Shanghai , American , Rui-hua-xu , Ben-atwell-alex-shaw , Zhou-yi , Panmure-gordon , Linkedin